ID: ALA4864914

Max Phase: Preclinical

Molecular Formula: C23H28F2N4O

Molecular Weight: 414.50

Molecule Type: Unknown

Representations

Canonical SMILES:  Fc1ccc(F)c(-c2ccc(N[C@H]3C[C@@H]4CN(CC5CCOCC5)C[C@@H]4C3)nn2)c1

Standard InChI:  InChI=1S/C23H28F2N4O/c24-18-1-2-21(25)20(11-18)22-3-4-23(28-27-22)26-19-9-16-13-29(14-17(16)10-19)12-15-5-7-30-8-6-15/h1-4,11,15-17,19H,5-10,12-14H2,(H,26,28)/t16-,17+,19+

Standard InChI Key:  ZRBSTYTUVKGMJH-DZFIZOCASA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 414.50

Molecular Weight (Monoisotopic): 414.2231

AlogP: 3.97

#Rotatable Bonds: 5

Polar Surface Area: 50.28

Molecular Species: BASE

HBA: 5

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 10.83

CX LogP: 3.02

CX LogD: -0.14

Aromatic Rings: 2

Heavy Atoms: 30

QED Weighted: 0.80

Np Likeness Score: -1.42

References

1. Spock M, Carter TR, Bollinger KA, Han C, Baker LA, Rodriguez AL, Peng L, Dickerson JW, Qi A, Rook JM, O'Neill JC, Watson KJ, Chang S, Bridges TM, Engers JL, Engers DW, Niswender CM, Conn PJ, Lindsley CW, Bender AM..  (2021)  Discovery of VU6028418: A Highly Selective and Orally Bioavailable M₄ Muscarinic Acetylcholine Receptor Antagonist.,  12  (8.0): [PMID:34413964] [10.1021/acsmedchemlett.1c00363]

Source

Source(1):

• Scientific Literature